| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/30/2007 | WO2007098356A1 Congeners of milnacipran as monoamine re-uptake |
| 08/30/2007 | WO2007098214A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors |
| 08/30/2007 | WO2007098169A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors |
| 08/30/2007 | WO2007097937A1 Pyrrolidine derivatives as erk inhibitors |
| 08/30/2007 | WO2007097697A1 Therapeutic quinoline compounds that are 5ht1b modulators |
| 08/30/2007 | WO2007097450A1 Compound with antimalarial activity and antimalarial drug containing the same as active ingredient |
| 08/30/2007 | WO2007097403A1 Remedy or preventive for digestive ulcer |
| 08/30/2007 | WO2007097276A1 Pyrrole derivative or salt thereof |
| 08/30/2007 | WO2007097197A1 Amide derivative or salt thereof |
| 08/30/2007 | WO2007096763A2 Melanocortin type 4 receptor agonist piperidinoylpyrrolidines |
| 08/30/2007 | WO2007096186A1 Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators |
| 08/30/2007 | WO2007095812A1 Substituted [1,3,5] triazine compounds, their processes for preparation and uses thereof |
| 08/30/2007 | WO2007079163A3 Prokineticin 1 receptor antagonists |
| 08/30/2007 | WO2007074238A3 Novel n-alk-(e)-ylidene-n'-pyrimidin-2-yl hydrazine derivatives and use thereof as cytoprotective drugs |
| 08/30/2007 | WO2007073303A3 Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors |
| 08/30/2007 | WO2007071632A3 2-pyridin-2-yl-quinazoline derivatives as potassium channel modulating agents for the treatment of respiratory diseases |
| 08/30/2007 | WO2007071455B1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs |
| 08/30/2007 | WO2007070556A3 N-(6-membered aromatic ring)-amido anti-viral compounds |
| 08/30/2007 | WO2007042912A3 Heterocyclic compounds as pstat3/il-6 inhibitors |
| 08/30/2007 | WO2007034329A3 Compounds and methods for treatment of amyloid-beta-peptide related disorders |
| 08/30/2007 | WO2007034326A3 Imidazole compounds for the treatment of neurological disorders |
| 08/30/2007 | WO2006015854A3 Azetidine derivatives as ccr-3 receptor antagonists |
| 08/30/2007 | US20070203342 Halogenation and oxidation of a 5-carboxyl-3-oxo-1-aryl-substituted-1H-pyrazolidine |
| 08/30/2007 | US20070203201 Substituted anthranilamides for controlling invertebrate pests |
| 08/30/2007 | US20070203194 Calcium channel modulators comprising 3-thio-4H-1,2,4-triazoles or S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 08/30/2007 | US20070203184 Novel Indolin-2-one Derivatives, Their Preparation and the Pharmaceutical Compositions Comprising Them |
| 08/30/2007 | US20070203183 Diaryl piperidines as CB1 modulators |
| 08/30/2007 | US20070203181 Quinoline Derivatives And Insecticide Comprising Thereof As Active Ingredient |
| 08/30/2007 | US20070203179 Azadecalin Glucocorticoid Receptor Modulators |
| 08/30/2007 | US20070203167 2-(Hetero)-aryl substituted tetrahydrochinoline |
| 08/30/2007 | US20070203152 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 08/30/2007 | US20070203151 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 08/30/2007 | US20070203150 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 08/30/2007 | US20070203141 Method for administering birb 796 bs |
| 08/30/2007 | US20070203138 Novel Compounds and Compositions as Cathepsin S Inhibitors |
| 08/30/2007 | US20070203132 2-{4-[4-(2-Ethyl-phenyl)-5-methyl-4H-[1,2,4]triazol-3-yl]-piperidin-1-yl}-pyrimidine; more potent, longer duration of action, broader range of activity, more stable, fewer side effects, selectivity; anxiety, cardiovascular disease, dysmenorrhoea, endometriosis, emesis, inflammation, sexual disorders |
| 08/30/2007 | US20070203129 2-Pyridone Derivatives As Neutrophil Elastase Inhibitors And Their Use |
| 08/30/2007 | US20070203101 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 08/30/2007 | US20070203072 Hcv Ns-3 Serine Protease Inhibitors |
| 08/30/2007 | US20070202181 Low hygroscopic aripipazole drug substance and processes for the preparation thereof |
| 08/30/2007 | US20070202174 New mandelic acid derivatives and their use as thrombin inhibitors |
| 08/30/2007 | US20070202133 BENZIMIDAZOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION |
| 08/30/2007 | US20070200490 Nitrogenous Heterocycle Derivative, And Organic Electroluminescent Element Employing The Same |
| 08/30/2007 | DE102005055726A1 Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Hydroxy-substituted Diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use |
| 08/30/2007 | CA2643983A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors |
| 08/30/2007 | CA2643963A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors |
| 08/30/2007 | CA2643272A1 Gent for treating or preventing digestive ulcer |
| 08/30/2007 | CA2642762A1 Pyrrolidine derivatives as erk inhibitors |
| 08/30/2007 | CA2642687A1 Crystal form of besipirdine chlorhydrate, process preparation and use thereof |
| 08/30/2007 | CA2642619A1 Pyrrole derivative or salt thereof |
| 08/30/2007 | CA2642610A1 Amide derivative or salt thereof |
| 08/30/2007 | CA2642229A1 Compositions and methods for inhibition of the jak pathway |
| 08/30/2007 | CA2637531A1 Compounds having 5-ht6 receptor affinity |
| 08/29/2007 | EP1826209A1 Nitromethylene derivatives and their use |
| 08/29/2007 | EP1824844A1 Pyrazine dicarboxamides and the use thereof |
| 08/29/2007 | EP1824841A1 Substituted pyrrole derivative |
| 08/29/2007 | EP1824840A1 Compounds having activity at nk3 receptor and uses thereof in medicine |
| 08/29/2007 | EP1824839A2 Substituted biaryl analogues |
| 08/29/2007 | EP1824838A1 Novel compounds |
| 08/29/2007 | EP1824832A1 Aryl-substituted benzimidazole and imidazopyridine ethers as anti-cancer agents |
| 08/29/2007 | EP1824831A2 Histone deacetylase inhibitors |
| 08/29/2007 | EP1824826A1 Aryl sulfonic pyridoxines as antiplatelet agents |
| 08/29/2007 | EP1824825A1 Substituted pyridoxines as anti-platelet agents |
| 08/29/2007 | EP1824823A1 Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues |
| 08/29/2007 | EP1824822A2 Novel 4-aminopiperidine derivatives as plasmepsin ii inhibitors |
| 08/29/2007 | EP1824817A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 08/29/2007 | EP1824490A1 Piperazinyl-pyridine analogues |
| 08/29/2007 | EP1725538B1 Pyridazinone ureas as antagonists of a4 integrins |
| 08/29/2007 | EP1643998B1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 08/29/2007 | EP1590344A4 Anti-cancer medicaments |
| 08/29/2007 | EP1549643B1 Method for preparing fused oxazinones from ortho-amino aromatic carboxylic acid and a carboxylic acid in the presence of a sulfonyl chloride and pyridine |
| 08/29/2007 | EP1351934B1 Naphthalene derivatives which bind to the ep4 receptor |
| 08/29/2007 | EP1337522B1 farnesyl protein transferase inhibitors |
| 08/29/2007 | EP1268431B1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 08/29/2007 | EP1105136B1 Method for treating ocular neovascular diseases |
| 08/29/2007 | CN101027295A Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 08/29/2007 | CN101027283A 3,4-disubstituted maleimides for use as vascular damaging agents |
| 08/29/2007 | CN101024671A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 08/29/2007 | CN101024642A Method for purifying 1-(5-nitro-III-indole-2-carbonyl)-4 {-[(1-methyl-ethyl)-amino]-2-pyridine} ethylene imine |
| 08/29/2007 | CN101024627A Nitrogen-containing aromatic derivatives |
| 08/29/2007 | CN101023946A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 08/29/2007 | CN100334083C Piperidine derivatives as CCR5 inhibitors |
| 08/29/2007 | CN100334082C Novel preparation process for 2 - methyl piperazine derivatives |
| 08/29/2007 | CN100334077C Benzimidazole derivatives and their use as GNRH antagonists |
| 08/28/2007 | US7262212 Antitubercular agent; antibiotic against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria; e.g. (R)-2-methyl-6-nitro-2-(4-(4-(4-trifluoromethoxyphenoxy)piperidin-1-yl)phenoxymethyl)-2,3-dihydroimidazo(2,1-b)oxazole |
| 08/28/2007 | US7262208 Hydroxypropyl amides for the treatment of Alzheimer's disease |
| 08/28/2007 | US7262207 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents |
| 08/28/2007 | US7262206 Having inhibiting effect on protein kinases, particularly an inhibiting effect on the activity of glycogen synthase kinase (GSK), for therapy of type II diabetes mellitus, diabetes associated disorders such as diabetic neuropathy, degenerative neurological diseases such as Alz-heimer's disease, stroke |
| 08/28/2007 | US7262205 Biphenyl compounds useful as muscarinic receptor antagonists |
| 08/28/2007 | US7262201 Quinazoline derivatives |
| 08/28/2007 | US7262196 Tri(cyclo) substituted amide glucokinase activator compounds |
| 08/28/2007 | US7262185 For therapy and prophylaxis of infectious diseases of HIV, in particular, AIDS and is also suitable for oral administration |
| 08/28/2007 | CA2342198C Therapeutic agent for spinal canal stenosis |
| 08/28/2007 | CA2290502C Treatment of hepatic cirrhosis |
| 08/28/2007 | CA2230960C Piperazine derivatives and process for the preparation thereof |
| 08/28/2007 | CA2160243C 36-derivatives of rifamycins and their use as antimicrobial agents |
| 08/23/2007 | WO2007095561A2 Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 08/23/2007 | WO2007095024A1 Metabotropic glutamate receptor-potentiating γsoindolones |
| 08/23/2007 | WO2007094513A2 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension |
| 08/23/2007 | WO2007094009A1 A novel process for preparation of aripiprazole and its intermediates |